Advertisement

A peptide enhancement strategy in Alzheimer's disease: Pilot study with TRH-physostigmine infusions

  • Alan M. Mellow
    Correspondence
    Address reprint requests to Alan M. Mellow, M.D., Ph.D., Department of Psychiatry, University of Michigan, 900 Wall Street, Ann Arbor, MI 48105.
    Footnotes
    Affiliations
    Department of Psychiatry, Ann Arbor, MI, USA

    Michigan Alzheimer's Disease Research Center, Ann Arbor, MI, USA

    University of Michigan Medical School, Ann Arbor, MI, USA

    Psychiatry Service, Ann Arbor VA Medical Center, Ann Arbor, MI, USA
    Search for articles by this author
  • Stephen M. Aronson
    Footnotes
    Affiliations
    Department of Psychiatry, Ann Arbor, MI, USA

    University of Michigan Medical School, Ann Arbor, MI, USA

    Psychiatry Service, Ann Arbor VA Medical Center, Ann Arbor, MI, USA
    Search for articles by this author
  • Bruno Giordani
    Footnotes
    Affiliations
    Department of Psychiatry, Ann Arbor, MI, USA

    Michigan Alzheimer's Disease Research Center, Ann Arbor, MI, USA

    University of Michigan Medical School, Ann Arbor, MI, USA
    Search for articles by this author
  • Stanley Berent
    Footnotes
    Affiliations
    Department of Psychiatry, Ann Arbor, MI, USA

    Michigan Alzheimer's Disease Research Center, Ann Arbor, MI, USA

    University of Michigan Medical School, Ann Arbor, MI, USA
    Search for articles by this author
  • Author Footnotes
    ∗ The authors wish to acknowledge the assistance of Dr. M. Hariharan for performing the hormonal assays.
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bartus R.T.
        • Dean III, R.L.
        • Beer B.
        • et al.
        The cholinergic hypothesis of geriatric memory dysfunction.
        Science. 1982; 217: 408-417
        • Bouloux P.
        • Perrett D.
        • Besser G.M.
        Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection.
        Ann Clin Biochem. 1985; 22: 194-203
        • Coyle J.T.
        • Price D.L.
        • DeLong M.R.
        Alzheimer's disease: a disorder of central cholinergic innervation.
        Science. 1983; 219: 1184-1190
        • Davis K.L.
        • Mohs R.C.
        Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.
        Am J Psychiatry. 1982; 139: 1421-1424
        • Davis K.L.
        • Thal L.J.
        • Gamzu E.R.
        • et al.
        A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
        N Engl J Med. 1992; 327: 1253-1259
        • Farlow M.
        • Gracon S.I.
        • Hershey L.A.
        • et al.
        A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.
        JAMA. 1992; 268: 2523-2529
        • Hokfelt T.
        • Millhorn D.
        • Seroogy K.
        • et al.
        Coexistence of peptides with classical neurotransmitters.
        Experientia Suppl. 1989; 56: 154-179
        • Horita A.
        • Carino M.A.
        • Lai H.
        Pharmacology of thyrotropin releasing hormone.
        Ann Rev Pharmacol Toxicol. 1986; 26: 311-332
        • Ishikawa Y.
        • Shimatsu A.
        • Kato Y.
        • et al.
        Effects of intrathecal administration of thyrotropin releasing hormone and its analogue, DN 1417, on plasma glucose and catecholamine levels in conscious rats.
        Brain Res. 1990; 514: 1-4
        • Janowsky D.S.
        • Risch S.C.
        • Huey L.Y.
        • et al.
        Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels.
        Am J Psychiatry. 1985; 142: 738-740
        • Kabayama Y.
        • Kato Y.
        • Tojo K.
        • et al.
        Central effects of DN1417, a novel TRH analog, on plasma glucose and catecholamines in conscious rats.
        Life Sci. 1985; 36: 1287-1294
        • Kennedy B.
        • Janowsky D.S.
        • Risch S.C.
        • et al.
        Central cholinergic stimulation causes adrenal epinephrine release.
        J Clin Invest. 1984; 74: 972-975
        • McKhann G.
        • Drachman D.
        • Folstein M.
        • et al.
        Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease.
        Neurology. 1984; 34: 939-944
        • Mellow A.M.
        • Sunderland T.
        • Cohen R.M.
        • et al.
        Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.
        Psychopharmacology. 1989; 98: 403-407
        • Mohs R.C.
        • Davis K.L.
        A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease.
        Neurobiol Aging. 1982; 3: 105-110
        • Molchan S.E.
        • Mellow A.M.
        • Lawlor B.A.
        • et al.
        TRH attenuates scopolamine-induced memory impairment in humans.
        Psychopharmacology. 1990; 100: 84-89
        • Morley J.E.
        • Tuck M.L.
        • Mayes D.M.
        • et al.
        Thyrotropin-releasing hormone increases plasma norepinephrine in man.
        Horm Res. 1981; 14: 18-23
        • Raskind M.A.
        • Peskind E.R.
        • Veith R.C.
        • et al.
        Neuroendocrine responses to physostigmine in Alzheimer's disease.
        Arch Gen Psychiatry. 1989; 46: 535-540
        • Thal L.J.
        • Masur D.M.
        • Blau A.D.
        • et al.
        Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.
        J Am Geriatr Soc. 1989; 37: 42-48
        • Voellmy D.R.
        • Kulling P.
        • Gramsch C.
        • et al.
        A novel two-site immunoradiometric assay for beta-endorphin using nitrocellulose as solid phase.
        Neurosci Biobehav Rev. 1988; 12: 199-204
        • Yarbrough G.G.
        Thyrotropin releasing hormone and CNS cholinergic neurons.
        Life Sci. 1983; 33: 111-118
        • Zaloga G.P.
        • Chernow B.
        • Zajtchuk R.
        • et al.
        Diagnostic dosages of protirelin (TRH) elevate BP by noncatecholamine mechanisms.
        Arch Intern Med. 1984; 144: 1149-1152